Journey Medical Corporation (DERM) financial statements (2022 and earlier)

Company profile

Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE, AZ 85258
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49,081
Cash and cash equivalents49,081
Receivables23,112
Inventory, net of allowances, customer advances and progress billings9,862
Inventory9,862
Other undisclosed current assets2,438
Total current assets:84,493
Noncurrent Assets
Operating lease, right-of-use asset89
Intangible assets, net (including goodwill)12,552
Intangible assets, net (excluding goodwill)12,552
Other noncurrent assets150
Total noncurrent assets:12,791
TOTAL ASSETS:97,284
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45,545
Accounts payable22,812
Accrued liabilities22,733
Debt812
Due to related parties589
Other undisclosed current liabilities4,660
Total current liabilities:51,606
Noncurrent Liabilities
Liabilities, other than long-term debt8
Accounts payable and accrued liabilities8
Other undisclosed noncurrent liabilities3,627
Total noncurrent liabilities:3,635
Total liabilities:55,241
Stockholders' equity
Stockholders' equity attributable to parent, including:42,043
Additional paid in capital80,915
Accumulated deficit(38,874)
Other undisclosed stockholders' equity attributable to parent2
Total stockholders' equity:42,043
TOTAL LIABILITIES AND EQUITY:97,284

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues63,134
Cost of revenue(32,084)
Gross profit:31,050
Operating expenses(42,572)
Other undisclosed operating loss(23,359)
Operating loss:(34,881)
Nonoperating expense(7,479)
Interest and debt expense(7,034)
Loss from continuing operations before equity method investments, income taxes:(49,394)
Other undisclosed income from continuing operations before income taxes7,034
Loss from continuing operations before income taxes:(42,360)
Income tax expense(1,634)
Net loss available to common stockholders, diluted:(43,994)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(43,994)
Comprehensive loss, net of tax, attributable to parent:(43,994)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: